Key findings from stage 1 of the PRESERVE-003 Phase 3 clinical trial conducted with participation from Florida Cancer Specialists & Research Institute, LLC (FCS) have shown that gotistobart, a novel ...

Researchers have built an AI-powered pathology tool designed to predict whether small cell lung cancer patients will respond ...

CLEVELAND, March 10, 2026 /PRNewswire/ -- Oncologists currently have limited tools to predict which lung cancer patients will benefit from immunotherapy. The publication of a multi-institutional study ...

Some studies have suggested that morning is the optimal time for immunotherapy, but a new analysis of patients with lung ...

Results of a new study conclude that a pathology tool powered by artificial intelligence can predict whether a patient with ...

Scientists, medical researchers at Case Western Reserve, NYU Langone Health and University Hospitals using machine-learning to predict response to immunotherapy Medical researchers from Case Western ...

Lung cancer survival rate: Small-cell lung cancer is one of the most dangerous cancers worldwide. Let us tell you what has been discovered about it, which has raised new hopes. Can AI predict cancer ...

Advances are reshaping treatment for small cell lung cancer, with immunotherapy and emerging options offering hope for longer survival and potential cures. Immunotherapy is changing treatment ...

Immunotherapy given during and after chemoradiation did not improve survival for study participants with limited-stage, small-cell lung cancer (SCLC) according to the results of an international ...

Asia-Pacific promises rapid growth, while increasing tobacco use and investments in oncology centers drive demand for ...

Lung cancer is often misunderstood, leading to delayed diagnosis and missed treatment opportunities. Experts debunk myths ...

Researchers have developed a pathology tool powered by AI that can predict whether a patient with extensive-stage small cell ...